Gapping down
In reaction to disappointing earnings/guidance: RADA -9.1%, SBLK -5.7%, SPLS -5.2%, CTXS -4%, (updates on its operations review, offers FY16 guidance, announces plan to spin off GoTo businesses, names new Chief Marketing Officer), SFUN -2.7%, SQM -2.1%, GILT -1.9%, MTSI -1.1%, AMCN -0.7%, GBDC -0.5%.
Other news: KBIO -12% (cont volatility pre-mkt), NBG -8.2% (cont volatility pre-mkt), SYT -4.8% (may be related to Reuters story regarging Bayer stating its crop chem business is not for sale), CLGX -3.8% (still checking), OME -3.3% (Wynnefield filed an amended 13D disclosing letter sent as follow up to several earlier communications detailing concerns and doubts related to the credibility of the 'purported strategic review process'),, QCOM -2.6% (announces receipt of report from Korea Fair Trade Commission alleging it violates Korean competition law), IBN -2.3% (Sensex down overnight), INFY -1.4% (Sensex down overnight), WMGI -0.9% (announced a secondary offering of 4.5 mln shares by an affiliate of Warburg Pincus), .
Analyst comments: DSX -4.6% (downgraded to Hold from Buy at Deutsche Bank), GPRO -3.8% (target lowered to $15 from $20 at Piper Jaffray), SGEN -3.2% (initiated with a Sell at Goldman
)
In reaction to disappointing earnings/guidance: RADA -9.1%, SBLK -5.7%, SPLS -5.2%, CTXS -4%, (updates on its operations review, offers FY16 guidance, announces plan to spin off GoTo businesses, names new Chief Marketing Officer), SFUN -2.7%, SQM -2.1%, GILT -1.9%, MTSI -1.1%, AMCN -0.7%, GBDC -0.5%.
Other news: KBIO -12% (cont volatility pre-mkt), NBG -8.2% (cont volatility pre-mkt), SYT -4.8% (may be related to Reuters story regarging Bayer stating its crop chem business is not for sale), CLGX -3.8% (still checking), OME -3.3% (Wynnefield filed an amended 13D disclosing letter sent as follow up to several earlier communications detailing concerns and doubts related to the credibility of the 'purported strategic review process'),, QCOM -2.6% (announces receipt of report from Korea Fair Trade Commission alleging it violates Korean competition law), IBN -2.3% (Sensex down overnight), INFY -1.4% (Sensex down overnight), WMGI -0.9% (announced a secondary offering of 4.5 mln shares by an affiliate of Warburg Pincus), .
Analyst comments: DSX -4.6% (downgraded to Hold from Buy at Deutsche Bank), GPRO -3.8% (target lowered to $15 from $20 at Piper Jaffray), SGEN -3.2% (initiated with a Sell at Goldman
)